Creators Explore Listeners

Blood & Cancer

Blood & Cancer

New

Old

Biosimilars with Dr. Gary Lyman

32:06

Advanced bladder cancer: Dr. Arjun Balar talks treatment strategies in a changing field

27:25

Gene therapies in hemophilia with Dr. Glenn Pierce

24:10

Thrombosis and thrombocytopenia caused by COVID-19 vaccines: How to identify and treat VITT, VIPIT, or TTS

23:11

Toward more personalized treatment in prostate cancer: The CCR score predicts metastasis and guides treatment decisions after radiation

28:23

Changing perspectives: Dr. Michael Weiner recounts his experiences as an oncologist who became a cancer patient and then a caregiver

25:28

Optimizing CAR T-cell therapies in lymphoma: Improving response, fighting cytokine release syndrome, and identifying mechanisms of resistance

25:38

Trends in genetic testing for breast and ovarian cancer: Undertesting and racial/ethnic disparities persist

26:43

Improving cancer screening in the COVID era: Drive By Flu-FIT allows for socially distanced colorectal cancer screening

31:22

Unpacking von Willebrand disease guidelines: Dr. Paula James talks diagnosis and pre-procedure prophylaxis

18:39

FDA approvals in hematology and oncology, Part II: New oral formulations, RET and MET inhibitors, and CAR T-cell therapies

20:16

How I treat CLL and MCL: From ‘watch and wait’ to BCL2 and BTK inhibitors, CAR T-cell therapy, and transplant

22:51

COVID-19 vaccination in cancer patients: Who should be vaccinated and when?

30:40

Managing pain in sickle cell crisis with Dr. Ifeyinwa Osunkwo

26:05

FDA approvals in hematology and oncology: Novel agents and new tricks for old drugs

23:25

NCI-MATCH trial reveals actionable mutations and matches cancer patients to targeted therapies

20:08

COVID-19 vaccine 101: Dr. Drew Weissman discusses mechanisms, efficacy, and vaccinating patients with cancer or HIV

23:45

Barriers to clinical trial enrollment for patients with gynecologic cancers: Why patients don’t participate and how to improve enrollment

21:38

Convalescent plasma for COVID-19, race linked to cancer-associated thrombosis risk, iron deficiency common in pregnancy, and more from ‘Best of ASH’

18:59

Thrombosis research from ASH 2020: Khorana score falls short in cancer study, factors predict VTE in cancer patients with COVID-19, and antithrombotics don’t affect severe COVID outcomes

24:31

Bullhorn

(519)

Get Started

Download the App

Terms of Service

Community Guidelines

Copyright @ 2022

Bullhorn

all right reserved.